COMPARISON OF SCORING SYSTEMS IN ASSESSING THE RISK OF MALIGNANCY IN OVARIAN CYSTS: A LITERATURE REVIEW AND CLINICAL IMPLICATIONS

I Gde Sastra Winata; Jessica Nathalia

doi:10.14710/dmj.v15i5.54325

DOI: https://doi.org/10.14710/dmj.v15i5.54325

COMPARISON OF SCORING SYSTEMS IN ASSESSING THE RISK OF MALIGNANCY IN OVARIAN CYSTS: A LITERATURE REVIEW AND CLINICAL IMPLICATIONS

*I Gde Sastra Winata

- Department of Obstetrics and Gynecology, Faculty of Medicine, Udayana University, Bali, Indonesia, Indonesia

Jessica Nathalia

- Department of Obstetrics and Gynecology, Faculty of Medicine, Udayana University, Bali, Indonesia, Indonesia

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Citation Format:

Abstract

Background: Preoperative assessment of ovarian cysts with suspected malignancy requires reliable scoring systems to distinguish between benign and malignant lesions. Several scoring systems have been developed, including the Risk of Malignancy Index (RMI), IOTA Simple Rules, and IOTA ADNEX. Objective: To review the literature on the diagnostic accuracy of these scoring systems, compare their strengths and weaknesses, and discuss their clinical implications. Methods: Literature search from open-access databases until the most recent articles, including studies comparing scoring systems for ovarian/adnexal masses. Results: Several studies show that IOTA models (especially ADNEX) have higher diagnostic performance (AUC) compared to RMI. However, each system has limitations in clinical applications. Conclusion: The choice of scoring system should consider local facilities (ultrasound, tumor markers, imaging expertise) and patient risk; the use of high-performing models can improve triage and management of patients with ovarian cysts.

Note: This article has supplementary file(s).

Fulltext View|Download | common.other

Cover Letter

Subject
Type	Other
	Download (22KB) Indexing metadata

Email colleagues

Keywords: ovarian cyst; adnexal mass; RMI; IOTA Simple Rules; IOTA ADNEX; malignancy risk score

Article Metrics:

Article Info

Section: Original Articles

Language : EN

In Vol 15, No 5 (2026): JURNAL KEDOKTERAN DIPONEGORO (DIPONEGORO MEDICAL JOURNAL)

Winata IGS, Pradnyana IWAS, Yusrika MU, Pradnyaandara IGBMA, Pradnyadevi PAS. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as an Early Prognostic Marker in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2024 Jun 1;25(6):1921-1927. doi: 10.31557/APJCP.2024.25.6.1921.PMID:38918652;PMCID:PMC11382835
Van Calster B, Van Hoorde K, Valentin L, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early- and advanced-stage invasive, and secondary metastatic tumors: prospective multicenter diagnostic study. BMJ. 2014;349:g5920
Sastra WIG, Aditya PPK, Gradiyanto OE, Ketut S. Predictive value of preoperative inflammatory markers and serum CA 125 level for surgical outcome in Indonesian women with epithelial ovarian cancer. Cancer Biomarkers. 2022;34(1):123-129. doi: 10.3233/CBM-201415
Mongan SP, Sutandar Y, Laihad BJ. The comparison of diagnostic accuracy of RMI to IOTA Simple Rules in diagnosing adnexal masses. Bali Med J. 2021;10(2):783-876
Lee SJ, Oh HR, Na S, Hwang HS, Lee SM. Ultrasonographic ovarian mass scoring system for predicting malignancy. [PMC article]. 2022. Available from: pmc.ncbi.nlm.nih.gov
Spagnol G, Marchetti M, Carollo M, et al. Clinical utility and diagnostic accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the prediction of malignancy in adnexal masses. Cancers. 2024;16:3790
Chankrachang A, Lattiwongsakorn W, Tantipalakorn C, Tongsong T. Diagnostic performance of ADNEX model and IOTA Simple Rules in differentiating malignant from benign adnexal masses when assessed by non-expert examiners. J Clin Med. 2025;14(8):2776
Simsek HS. Role of a Risk of Malignancy Index in Clinical Approaches to Adnexal Masses. Asian Pac J Cancer Prev. 2014;15:2929-32
Kougioumtsidou A, et al. Performance of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Screening of Adnexal Masses. 2025
Hiett AK, Sonek JD, Guy M, Reid TJ. Performance of IOTA Simple Rules, IOTA ADNEX, and O-RADS in differentiating between benign and malignant adnexal lesions. Ultrasound Obst Gynecol. 2022;59:668-676
Yoeli-Bik R, Longman RE, Wroblewski K, et al. Diagnostic performance of ultrasonography-based risk models for ovarian tumors. JAMA Netw Open. 2023;6(9):e2807189

Last update:

No citation recorded.

Last update:

No citation recorded.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC-BY-NC-SA) that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal. - Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).